OrthoPediatrics (KIDS) Revenue & Revenue Breakdown
OrthoPediatrics Revenue Highlights
Latest Revenue (Y)
$236.35M
Latest Revenue (Q)
$61.25M
Main Segment (Y)
Trauma and Deformity
Main Geography (Y)
UNITED STATES
OrthoPediatrics Revenue by Period
OrthoPediatrics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | $236.35M | 15.45% |
| 2024-12-31 | $204.73M | 37.65% |
| 2023-12-31 | $148.73M | 21.62% |
| 2022-12-31 | $122.29M | 24.72% |
| 2021-12-31 | $98.05M | 37.95% |
| 2020-12-31 | $71.08M | -2.03% |
| 2019-12-31 | $72.55M | 26.05% |
| 2018-12-31 | $57.56M | 26.17% |
| 2017-12-31 | $45.62M | 22.31% |
| 2016-12-31 | $37.30M | 20.30% |
| 2015-12-31 | $31.00M | 30.91% |
| 2014-12-31 | $23.68M | - |
OrthoPediatrics generated $236.35M in revenue during NA 2025, up 15.45% compared to the previous quarter, and up 332.52% compared to the same period a year ago.
OrthoPediatrics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | $61.25M | 0.28% |
| 2025-06-30 | $61.08M | 16.54% |
| 2025-03-31 | $52.41M | -0.49% |
| 2024-12-31 | $52.67M | -3.49% |
| 2024-09-30 | $54.57M | 3.35% |
| 2024-06-30 | $52.80M | 18.16% |
| 2024-03-31 | $44.69M | 18.80% |
| 2023-12-31 | $37.61M | -5.90% |
| 2023-09-30 | $39.97M | 1.04% |
| 2023-06-30 | $39.56M | 25.23% |
| 2023-03-31 | $31.59M | 1.92% |
| 2022-12-31 | $30.99M | -11.32% |
| 2022-09-30 | $34.95M | 6.14% |
| 2022-06-30 | $32.93M | 40.62% |
| 2022-03-31 | $23.42M | -5.63% |
| 2021-12-31 | $24.81M | -1.06% |
| 2021-09-30 | $25.08M | -6.05% |
| 2021-06-30 | $26.70M | 24.38% |
| 2021-03-31 | $21.46M | 13.41% |
| 2020-12-31 | $18.92M | -14.78% |
| 2020-09-30 | $22.20M | 63.36% |
| 2020-06-30 | $13.59M | -16.89% |
| 2020-03-31 | $16.36M | -13.70% |
| 2019-12-31 | $18.95M | -8.64% |
| 2019-09-30 | $20.74M | 13.98% |
| 2019-06-30 | $18.20M | 24.18% |
| 2019-03-31 | $14.66M | 0.60% |
| 2018-12-31 | $14.57M | -7.91% |
| 2018-09-30 | $15.82M | 4.93% |
| 2018-06-30 | $15.08M | 24.67% |
| 2018-03-31 | $12.09M | 3.54% |
| 2017-12-31 | $11.68M | -5.61% |
| 2017-09-30 | $12.38M | 4.86% |
| 2017-06-30 | $11.80M | 20.90% |
| 2017-03-31 | $9.76M | 3.65% |
| 2016-12-31 | $9.42M | -7.07% |
| 2016-09-30 | $10.13M | 4.77% |
| 2016-06-30 | $9.67M | 19.86% |
| 2016-03-31 | $8.07M | 30.60% |
| 2015-03-31 | $6.18M | - |
OrthoPediatrics generated $61.25M in revenue during Q3 2025, up 0.28% compared to the previous quarter, and up 116.00% compared to the same period a year ago.
OrthoPediatrics Revenue Breakdown
OrthoPediatrics Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Trauma and Deformity | $166.30M | $145.13M | $106.78M | $85.06M | $65.83M |
| Spine | $66.05M | $55.15M | $37.93M | $33.43M | $28.05M |
| Sports Medicine And Other | $4.00M | - | - | - | - |
| ACL Reconstruction and Other | - | $4.45M | $4.02M | $3.81M | $4.17M |
OrthoPediatrics's latest annual revenue breakdown by segment (product or service), as of Dec 25: Trauma and Deformity (70.36%), Spine (27.94%), and Sports Medicine And Other (1.69%).
Quarterly Revenue by Product
| Product/Service | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Spine | $17.60M | $16.26M | $18.52M | $13.66M | $29.32M | $15.63M | $10.20M | $9.66M | $10.30M | $10.89M | $7.07M | $8.04M | $9.98M | $9.42M | $5.98M | $7.17M | $7.27M | $7.66M | $6.64M | - |
| Sports Medicine And Other | $1.37M | $846.00K | $905.00K | $880.00K | $1.30M | $1.18M | $862.00K | $1.15M | $1.12M | $1.08M | $939.00K | $918.00K | $996.00K | $1.10M | - | - | - | - | - | - |
| Trauma And Deformity | - | $44.14M | $41.66M | $37.87M | $37.64M | $33.30M | $28.81M | $27.51M | $23.39M | $23.89M | - | - | - | - | - | - | - | - | - | - |
| Trauma and Deformity | - | - | - | - | - | - | - | - | - | - | - | - | - | $22.57M | $16.52M | $16.82M | $17.93M | $14.55M | - | - |
| SpineMember | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $5.95M | - |
| SportsMedicineandOtherMember | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $959.00K | - |
OrthoPediatrics's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: Spine (92.78%), and Sports Medicine And Other (7.22%).
OrthoPediatrics Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| UNITED STATES | $186.40M | $161.16M | $111.01M | $92.42M | $77.78M |
| Non-US | $49.95M | $43.56M | $37.72M | $29.87M | $20.27M |
OrthoPediatrics's latest annual revenue breakdown by geography, as of Dec 25: UNITED STATES (78.87%), and Non-US (21.13%).
Quarterly Revenue by Country
| Country | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Sep 21 | Jun 21 | Mar 21 | Sep 20 | Jun 20 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-US | $12.96M | $12.53M | $12.94M | $11.52M | $21.32M | $11.86M | $10.38M | $9.35M | $10.61M | $9.97M | $7.79M | $8.26M | $8.41M | $7.97M | $5.23M | $5.72M | $4.96M | $4.62M | $2.62M | $1.45M |
| UNITED STATES | $48.65M | $48.72M | $48.15M | $40.89M | $84.14M | $42.71M | $34.30M | $28.26M | $29.36M | $29.59M | $23.80M | $22.73M | $26.54M | $24.96M | $18.19M | $19.35M | $21.74M | $16.84M | $19.58M | $12.15M |
OrthoPediatrics's latest quarterly revenue breakdown by geography, as of Dec 25: UNITED STATES (78.97%), and Non-US (21.03%).
OrthoPediatrics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| EHAB | Enhabit | $1.06B | $266.10M |
| BVS | Bioventus | $568.09M | $138.65M |
| TOI | Oncology Institute | $502.73M | $136.56M |
| EOLS | Evolus | $294.96M | $68.97M |
| KIDS | OrthoPediatrics | $236.35M | $61.25M |
| TMCI | Treace Medical Concepts | $212.69M | $47.39M |
| RXST | RxSight | $134.48M | $33.64M |
| SRDX | Surmodics | $126.08M | $28.09M |
| CBLL | CeriBell | $89.06M | $22.59M |
| LAB | Standard BioTools | $85.33M | $19.55M |
| SMLR | Semler Scientific | $56.29M | $7.49M |